Invention Grant
- Patent Title: Compounds and compositions as protein kinase inhibitors
-
Application No.: US13931111Application Date: 2013-06-28
-
Publication No.: US09314464B2Publication Date: 2016-04-19
- Inventor: Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/535
- IPC: A61K31/535 ; A61K31/506 ; C07D401/14 ; C07D403/04 ; A61K45/06 ; C07D405/14
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
Public/Granted literature
- US20130296318A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS Public/Granted day:2013-11-07
Information query
